These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4087193)

  • 1. Liquid chromatographic determination of dihydralazine and hydralazine in human plasma and its application to pharmacokinetic studies of dihydralazine.
    Rouan MC; Campestrini J
    J Pharm Sci; 1985 Dec; 74(12):1270-3. PubMed ID: 4087193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations and pharmacokinetics of dihydralazine after single oral doses to human subjects.
    Waller AR; Chasseaud LF; Taylor T; Darragh A; O'Kelly DA
    Biopharm Drug Dispos; 1979; 1(2):59-64. PubMed ID: 552862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatographic determination of hydralazine in human plasma with 2-hydroxy-1-naphthaldehyde pre-column derivatization.
    Mañes J; Mari J; Garcia R; Font G
    J Pharm Biomed Anal; 1990; 8(8-12):795-8. PubMed ID: 2100625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic determination of dihydralazine in human plasma.
    Waller AR; Chasseaud LF; Taylor T
    J Chromatogr; 1979 May; 173(1):202-7. PubMed ID: 546874
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of apparent dihydralazine in plasma by gas--liquid chromatography and electron-capture detection.
    Degen PH; Brechbühler S; Schneider W; Zbinden P
    J Chromatogr; 1982 Dec; 233():375-80. PubMed ID: 7161351
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions of dihydralazine with furosemide in hypertonic patients.
    Siegmund W; Kairies M; Franke G; Donner I; Biebler KE
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):148-51. PubMed ID: 3557742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the kinetics and distribution of dihydralazine in pregnancy.
    Franke G; Pietsch P; Schneider T; Siegmund W; Grabow D; Schütz H
    Biol Res Pregnancy Perinatol; 1986; 7(1):30-3. PubMed ID: 3955125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective high-performance liquid chromatographic assays for hydralazine and its metabolites in plasma of man.
    Reece PA; Cozamanis I; Zacest R
    J Chromatogr; 1980 Mar; 181(3-4):427-40. PubMed ID: 7391156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative determination and kinetics of dihydralazine in hypertension patients].
    Siegmund W; Zschiesche M; Kallwellis R; Franke G; Schneider T; Sill U; Scherber A; Hüller H
    Pharmazie; 1985 Nov; 40(11):779-81. PubMed ID: 4095128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The quantitative determination of dihydralazine and selected metabolites in man].
    Schneider T; Siegmund W; Zschiesche M; Kallwellis R
    Pharmazie; 1988 Oct; 43(10):704-6. PubMed ID: 3212018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hydralazine and dihydralazine on connective tissue and binding to serum protein.
    Blumenkrantz N; Christiansen AH; Asboe-Hansen G
    Scand J Rheumatol; 1979; 8(3):177-83. PubMed ID: 227048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The determination of hydralazine in plasma by gas-liquid chromatography.
    Jack DB; Brechbüher S; Degen PH; Zbinden P; Riess W
    J Chromatogr; 1975 Dec; 115(1):87-92. PubMed ID: 1202076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive high-performance liquid chromatographic assay for endralazine and two of its metabolites in human plasma.
    Reece PA; Cozamanis I; Zacest R
    J Chromatogr; 1981 Sep; 225(1):151-60. PubMed ID: 7298742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clonidine and dihydralazine on plasma ANF and cyclic GMP levels in humans during volume loading.
    Müller T; Heim JM; Weil J; Wehling M; Witzgall H; Gerzer R
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S163-6. PubMed ID: 2455172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of hydralazine in human plasma by high-performance liquid chromatography with electrochemical detection.
    Wong JK; Joyce TH; Morrow DH
    J Chromatogr; 1987 Jan; 385():261-6. PubMed ID: 3558580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-pressure liquid chromatographic assay for hydralazine in human plasma.
    Ludden TM; Goggin LK; McNay JL; Haegele KD; Shepherd AM
    J Pharm Sci; 1979 Nov; 68(11):1423-5. PubMed ID: 512893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of tegaserod by LC-ESI-MS/MS and its application to a pharmacokinetic study in healthy Chinese volunteers.
    Zou JJ; Bian XJ; Ding L; Zhu YB; Fan HW; Xiao DW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):151-7. PubMed ID: 18069077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of myeloperoxidase and elastase enzyme activity with the antihypertensive agents hydralazine and dihydralazine.
    Hansson AL; Nässberger L
    Pharmacol Toxicol; 1993 Aug; 73(2):75-8. PubMed ID: 8248010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydralazine sulfate analysis using 2-methyl-o-nitropyridine-6-carboxaldehyde.
    Youssef AF; Ibrahim SA; Elshabouri SR
    J Pharm Sci; 1977 Jan; 66(1):116-8. PubMed ID: 833726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxicity of the antihypertensive drugs hydralazine and dihydralazine.
    Williams GM; Mazue G; McQueen CA; Shimada T
    Science; 1980 Oct; 210(4467):329-30. PubMed ID: 7423193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.